Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeEXECUTIVESDominic Paniccia Becomes New CEO at Integra Partners

Dominic Paniccia Becomes New CEO at Integra Partners

Dominic Paniccia has been appointed new CEO effective March 31, 2019. Paniccia succeeds Andrew Saltoun, who will continue to serve as a senior advisor to the organization.

Paniccia joined Integra Partners in 2016, first serving as chief financial officer, and was appointed president in 2018, assuming the day-to-day activities of the organization. In the past year under his leadership, the company has seen significant growth and looks to continue upon that progress as it continues to expand its network.  Among Paniccia’s more recent achievements at Integra is the creation of a new customer-centric model which has improved operations and increased revenues.

Tom Croswell, president and CEO of Tufts Health Plan, and an Integra Partners board director, said: “This is a great time in the history of Integra Partners.  We are grateful to Andrew for bringing the company to where it is today, and we are looking forward to working with Dom and his team to continue upon the positive results and momentum they have achieved in the past year.”

“I’m honored to be appointed to this position,” said Paniccia.  “Integra is growing, and we’re focused on doing what we can to achieve our mission of reducing the friction in health care – making things easier for our clients, which includes health plans and providers – as we manage these benefits.”

Paniccia’s career has spanned several industries, including financial services, information management and health care.  Prior to joining Integra Partners, he held leadership positions at American Express, AIG and CB Insights. He earned his M.B.A from Fordham University and his B.S. from Manhattan College.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy